Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial. uri icon

authors

  • Tada, Atsushi
  • Testani, Jeffrey M
  • Julio A. Chirinos, MD, PhD
  • Borlaug, Barry A
  • Burkhoff, Daniel
  • Naser, Jwan A
  • Harada, Tomonari
  • Pourmussa, Bianca
  • Reddy, Yogesh N V
  • Jensen, Michael D
  • Carter, Rickey E
  • Demmer, Ryan T

publication date

  • August 5, 2024